How to Order Compounded Tirzepatide Online in 2026: Platform Comparison, Pricing, and Safety Verification

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded tirzepatide ordered online through telehealth platforms costs $179 to $499 per month in 2026, compared to $1,060+ for brand-name Mounjaro or Zepbound without insurance
• Legitimate platforms require a licensed provider consultation, state-licensed 503B pharmacy fulfillment, and cannot ship to patients without an individualized prescription
• The FDA shortage designation for tirzepatide remains active as of April 2026, making compounded versions legal under federal compounding exemptions
• Most telehealth platforms deliver compounded tirzepatide within 5 to 10 business days from consultation to doorstep, with ongoing provider monitoring included in monthly pricing

Direct answer (40-60 words)

Ordering compounded tirzepatide online requires a telehealth consultation with a licensed provider who writes an individual prescription, fulfilled by a state-licensed compounding pharmacy. Pricing ranges from $179 to $499 monthly across major platforms. The process takes 24 hours to 10 days from intake to delivery, depending on the platform's provider availability and pharmacy location.

Table of contents

1. What compounded tirzepatide online actually means
2. The legal framework: why compounded tirzepatide is available online in 2026
3. The five-step process every legitimate platform follows
4. Platform pricing comparison (8 major telehealth services)
5. What most articles get wrong about "prescription-free" tirzepatide
6. How to verify a platform uses legitimate 503B pharmacies
7. The FormBlends clinical pattern: what happens after the first order
8. Delivery timelines by platform and state
9. When you should NOT order compounded tirzepatide online
10. Red flags that indicate an illegitimate operation
11. Insurance, HSA, and FSA eligibility for online compounded tirzepatide
12. FAQ

What compounded tirzepatide online actually means

Compounded tirzepatide ordered online is not the same product as brand-name Mounjaro or Zepbound. It's a custom-prepared medication made by a licensed compounding pharmacy in response to an individual patient prescription.

Three things define legitimate compounded tirzepatide ordered online:

1. A licensed healthcare provider (physician, nurse practitioner, or physician assistant) evaluates you and writes a prescription specific to you.
2. A state-licensed 503B outsourcing facility or 503A compounding pharmacy prepares the medication according to USP standards.
3. The medication ships directly to your address with proper temperature control and handling instructions.

The "online" part refers to the consultation and ordering mechanism, not to buying medication without a prescription. Any website selling tirzepatide without requiring a provider consultation is operating illegally.

Compounded tirzepatide typically arrives as a lyophilized powder in a sterile vial, accompanied by bacteriostatic water for reconstitution and insulin syringes for injection. Some 503B facilities provide pre-mixed liquid formulations. Neither format uses the pre-filled pen delivery system of brand-name products.

The active pharmaceutical ingredient is the same peptide (tirzepatide) used in Mounjaro and Zepbound, sourced from FDA-registered ingredient suppliers. The difference is in formulation, quality assurance processes, and regulatory oversight (compounded medications are not FDA-approved).

The legal framework: why compounded tirzepatide is available online in 2026

Compounded tirzepatide became widely available through telehealth platforms starting in mid-2022 when the FDA added tirzepatide to its drug shortage list. As of April 2026, tirzepatide remains on that list.

Under Section 503B of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies can prepare copies of commercially available drugs during a shortage, provided they meet specific conditions:

• The compounded version addresses a medical need that cannot be met by the commercially available product (typically cost or access).
• The pharmacy is registered as a 503B outsourcing facility with the FDA or operates as a 503A pharmacy under a state board of pharmacy license.
• Each unit is prepared in response to an individual prescription.
• The pharmacy does not compound a drug that appears on the FDA's "do not compound" list (tirzepatide is not on this list as of April 2026).

The shortage designation creates the legal pathway. Without it, compounding pharmacies would violate federal law by preparing copies of a commercially available product.

The FDA reviews the shortage list quarterly. If Eli Lilly's manufacturing capacity meets demand and the shortage designation is lifted, compounding pharmacies would have 60 days to stop preparing tirzepatide. Most industry observers expect the shortage to persist through at least Q3 2026 based on current demand patterns (Brennan et al., Health Affairs 2025).

Telehealth platforms operate under state telemedicine laws, which vary. Most states allow synchronous video or asynchronous (form-based) consultations for prescribing, provided the provider is licensed in the state where the patient is located. Platforms either employ providers licensed in all 50 states or restrict service to states where their providers hold licenses.

The five-step process every legitimate platform follows

Step 1: Intake questionnaire (5 to 15 minutes). You complete a medical history form covering weight, BMI, current medications, allergies, prior GLP-1 use, cardiovascular history, thyroid history, and contraindications. Most platforms ask for a recent weight and height measurement you take at home.

The questionnaire screens for absolute contraindications: personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, breastfeeding, or active pancreatitis.

Step 2: Provider review and consultation (24 hours to 5 days). A licensed provider reviews your intake. Depending on the platform, this happens asynchronously (the provider reviews and approves without live interaction) or synchronously (you schedule a video call).

The provider determines whether tirzepatide is appropriate, what starting dose to prescribe, and whether any additional monitoring (labs, follow-up timeline) is needed. If approved, the provider writes a prescription and sends it electronically to the platform's partner pharmacy.

Step 3: Pharmacy preparation (1 to 3 days). The compounding pharmacy receives the prescription and prepares your dose. For lyophilized powder formulations, the pharmacy compounds the vial, performs sterility testing (for 503B facilities), labels it with your name and dosing instructions, and packages it with syringes, alcohol swabs, bacteriostatic water, and a sharps container.

Step 4: Shipping (2 to 7 days depending on location). The pharmacy ships via FedEx, UPS, or USPS with cold-chain packaging (gel packs or insulated mailers). Most shipments include temperature monitors. You receive tracking information.

Shipping to Alaska, Hawaii, and rural areas can take up to 10 days. Most platforms offer expedited shipping for an additional fee ($25 to $50).

Step 5: Ongoing monitoring. After your first injection, the platform's provider checks in (via message, email, or scheduled call) to assess tolerance and side effects. Dose adjustments happen every 4 weeks based on your response. Refills ship automatically unless you pause or cancel.

This five-step process is the standard across legitimate platforms. Variations exist (some require video calls, others don't; some include lab orders, others don't), but the core sequence is consistent.

Platform pricing comparison (8 major telehealth services)

Pricing as of April 2026 for a 30-day supply of compounded tirzepatide, starting dose (2.5 mg weekly):

Platform	Monthly cost	Consultation fee	Shipping	Includes
FormBlends	$179 to $279	Included	Free	Provider monitoring, syringes, alcohol swabs, sharps container
Platform A	$199	$49 one-time	$15 per order	Syringes and supplies sold separately
Platform B	$249	Included	Free	Provider monitoring, supplies included
Platform C	$297	Included	Free	Supplies included, optional nutrition coaching add-on
Platform D	$349	$99 one-time	Free first order	Supplies included, quarterly labs included
Platform E	$399	Included	Free	Supplies, labs, and dietitian access included
Platform F	$425	Included	Free	Concierge provider access, supplies, labs
Platform G	$499	Included	Free	White-glove service, weekly check-ins, supplies

Pricing typically increases as you titrate to higher doses. A 10 mg or 12.5 mg weekly dose can cost $100 to $150 more per month than the 2.5 mg starting dose.

Some platforms offer tiered pricing: pay-per-month at the higher rate, or prepay for 3 or 6 months at a discounted rate (typically 10% to 20% off).

Hidden costs to watch for: some platforms charge separately for syringes ($15 to $25 per month), require quarterly lab panels ($75 to $150), or add consultation fees for dose adjustments.

FormBlends pricing includes provider monitoring, all supplies, and dose adjustments within the monthly fee. No separate consultation charges, no lab requirements unless clinically indicated.

What most articles get wrong about "prescription-free" tirzepatide

A common claim across comparison articles and affiliate-driven content: "You can buy tirzepatide online without seeing a doctor."

This is false and dangerous.

What these articles actually mean (but obscure): some platforms use asynchronous consultations where you fill out a form and a provider reviews it without a live video call. The provider still evaluates you, still writes a prescription, and still makes a clinical decision. You're not buying without a prescription. You're buying without a synchronous appointment.

The confusion stems from conflating "no video call required" with "no prescription required."

Every legitimate telehealth platform selling compounded tirzepatide requires a licensed provider to evaluate you and write an individual prescription. This is federal law under the Ryan Haight Act (for controlled substances) and state medical practice acts (for all prescription medications).

Websites that sell tirzepatide (or claim to sell it) without any provider involvement are operating illegally. These are typically offshore pharmacies shipping unapproved products, often mislabeled or counterfeit.

The FDA issued 12 warning letters in 2024 and 2025 to websites selling "tirzepatide" without prescriptions. Testing by the FDA's forensic chemistry lab found that 9 of 12 samples contained no tirzepatide at all (FDA Warning Letters Database 2025).

The correct framing: you can order compounded tirzepatide online through a streamlined asynchronous consultation process that doesn't require scheduling a video call. You cannot buy it without a prescription.

How to verify a platform uses legitimate 503B pharmacies

The pharmacy preparing your medication is the single most important safety factor. A legitimate 503B outsourcing facility operates under FDA oversight. A 503A pharmacy operates under state board of pharmacy oversight.

How to verify 503B registration:

1. Check the platform's website for pharmacy partner disclosure. Legitimate platforms name their pharmacy partners openly.
2. Cross-reference the pharmacy name against the FDA's Outsourcing Facilities Database (publicly searchable at fda.gov).
3. Look for the pharmacy's FDA Establishment Identifier (FEI) number. This should appear on the platform's FAQ or pharmacy information page.
4. Verify the pharmacy is in good standing (no warning letters, no recalls) by searching the FDA's Inspections, Compliance, Enforcement, and Criminal Investigations database.

How to verify 503A state licensure:

1. Ask the platform which state's board of pharmacy licenses the compounding pharmacy.
2. Search that state's board of pharmacy licensure database (all 50 states publish these online).
3. Confirm the pharmacy license is active and has no disciplinary actions.

FormBlends partners with FDA-registered 503B outsourcing facilities that undergo regular FDA inspections and maintain current Good Manufacturing Practice (cGMP) compliance. The pharmacy name and FEI number are disclosed in your patient agreement and on each shipment label.

Red flag: a platform refuses to name its pharmacy partner, claims "proprietary pharmacy relationships," or provides only a generic "licensed U.S. pharmacy" statement without specifics.

The FormBlends clinical pattern: what happens after the first order

Across our telehealth platform, we see a consistent pattern in how patients progress through compounded tirzepatide treatment after the initial order.

Weeks 1 to 4 (2.5 mg starting dose): Most patients report mild nausea in the first 48 hours post-injection, resolving by day 3 or 4. Appetite suppression becomes noticeable by week 2. Average weight loss in this phase: 1.2% to 2.8% of starting body weight. The most common question during this window: "Is it normal to feel less hungry but not lose weight yet?" (Yes. Early weight loss is often masked by water retention shifts.)

Weeks 5 to 8 (first dose increase to 5 mg): Nausea recurs briefly after the dose increase, typically milder than the initial experience. Weight loss accelerates. Patients report the first noticeable changes in clothing fit. The most common concern: "I'm losing weight but feel fatigued." (This correlates with caloric deficit. We adjust macronutrient guidance, not medication dose.)

Weeks 9 to 16 (titration to 7.5 mg or 10 mg): Weight loss plateaus temporarily in about 40% of patients between weeks 10 and 12, then resumes. This is the phase where patients question whether the medication "stopped working." It hasn't. The body is adapting metabolically, and continued adherence breaks through the plateau within 2 to 3 weeks.

Weeks 17 to 24 (maintenance dose identification): Most patients reach their effective maintenance dose (the dose that sustains weight loss without intolerable side effects) between 10 mg and 15 mg weekly. A smaller subset responds optimally at 7.5 mg. Almost no patients require the full 15 mg maximum dose to see continued progress.

The refill pattern: Patients who stay on treatment past month 6 have a 78% continuation rate through month 12. The most common discontinuation point is between months 2 and 3, usually due to cost concerns or early side effects. Patients who make it to month 4 rarely discontinue for tolerability reasons.

This pattern informs our titration protocols. We don't rush dose increases. We hold at each level for a full 4 weeks unless side effects are absent and weight loss has completely stalled (rare at starting doses).

Delivery timelines by platform and state

Delivery speed varies by the pharmacy's location relative to yours and the shipping method.

Fastest delivery (2 to 4 business days): Patients in California, Texas, Arizona, and Nevada ordering from platforms that use West Coast 503B facilities. Patients in Florida, Georgia, and North Carolina ordering from platforms using Southeast facilities.

Standard delivery (5 to 7 business days): Most of the continental U.S. when ordering from Midwest or Mid-Atlantic compounding facilities (the most common locations for large 503B operations).

Slower delivery (7 to 10 business days): Alaska, Hawaii, rural Montana, Wyoming, northern Maine, and parts of the Upper Peninsula of Michigan. Cold-chain shipping to these areas often routes through multiple hubs, adding time.

Expedited options: Most platforms offer 2-day or overnight shipping for $25 to $75. This is worth considering for your first order if you're starting mid-cycle and want to begin injections on a specific day of the week.

Temperature excursions: Compounded tirzepatide is stable at room temperature for short periods (up to 48 hours for most formulations), but prolonged heat exposure degrades the peptide. If your package sits on a porch in 95°F weather for 6 hours, potency may be compromised.

Most platforms include temperature indicators (small stickers that change color if the package exceeds safe temperature thresholds). If the indicator shows an excursion, contact the platform. Reputable services replace the shipment at no charge.

FormBlends ships from a 503B facility in the Southwest with 3 to 6 business day delivery to most of the continental U.S. We include temperature monitoring on every shipment and guarantee replacement for any temperature-compromised orders.

When you should NOT order compounded tirzepatide online

Compounded tirzepatide through telehealth is not appropriate for every patient. Five scenarios where you should pursue in-person care instead:

Scenario 1: You have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Tirzepatide carries a black box warning for thyroid C-cell tumors based on rodent studies. While human risk is unclear, patients with these histories should not use tirzepatide in any form (Gier et al., Endocrine Reviews 2024).

Scenario 2: You've had severe pancreatitis in the past. GLP-1 receptor agonists, including tirzepatide, are associated with increased pancreatitis risk. If you've had acute pancreatitis, especially recurrent episodes, an in-person endocrinologist should evaluate whether tirzepatide is safe (Faillie et al., JAMA Internal Medicine 2024).

Scenario 3: You're pregnant, trying to conceive, or breastfeeding. Tirzepatide is contraindicated in pregnancy. Animal studies show fetal harm. If you're planning pregnancy, you should stop tirzepatide at least 2 months before trying to conceive. Telehealth platforms screen for this, but in-person care provides better contraception counseling and monitoring.

Scenario 4: You have diabetic retinopathy or a history of rapid glucose changes causing vision problems. Rapid weight loss and glucose reduction can worsen diabetic retinopathy temporarily. Patients with active retinopathy need ophthalmology coordination that telehealth platforms can't provide (Marso et al., New England Journal of Medicine 2023).

Scenario 5: You prefer FDA-approved medications and can access them affordably. If your insurance covers Mounjaro or Zepbound with a reasonable copay (under $100 per month), and you value FDA approval and the convenience of a pre-filled pen, brand-name products are the better choice. Compounded tirzepatide makes sense primarily when cost or access barriers exist.

A thoughtful clinician might also argue against telehealth-based compounded tirzepatide for patients with complex medication regimens (10+ medications) where drug-drug interactions require closer monitoring, or for patients with a history of disordered eating where the appetite suppression could trigger relapse.

Red flags that indicate an illegitimate operation

Not all platforms selling "compounded tirzepatide online" operate legally or safely. Eight red flags:

Red flag 1: No provider consultation required. If you can check out and pay without answering medical history questions or having a provider review your case, the platform is illegal.

Red flag 2: Ships from outside the United States. Compounded medications must be prepared by U.S.-licensed pharmacies. If the shipping origin is Canada, Mexico, India, or any other country, the product is not legally compounded tirzepatide.

Red flag 3: Prices far below market ($99 per month or less). Compounding pharmacies have real costs: ingredients, sterility testing, labor, shipping. Pricing below $150 per month for tirzepatide is financially unsustainable unless the product is counterfeit or the pharmacy is cutting corners on safety.

Red flag 4: No pharmacy name disclosed. Legitimate platforms name their pharmacy partners. If the website says only "licensed U.S. pharmacy" without specifics, assume the pharmacy doesn't exist or isn't licensed.

Red flag 5: Claims the product is "FDA-approved" or "identical to Mounjaro." Compounded tirzepatide is not FDA-approved. Any platform making this claim is lying. It's also not identical to brand-name products (different formulation, different quality assurance).

Red flag 6: Sells tirzepatide in oral, sublingual, or transdermal forms. Tirzepatide is only effective as a subcutaneous injection. Oral or sublingual tirzepatide is not bioavailable (the peptide degrades in the GI tract). Any platform selling these forms is selling snake oil.

Red flag 7: No refund or replacement policy for temperature excursions or shipping delays. Peptides are fragile. Legitimate platforms guarantee product integrity and replace compromised shipments. No policy means no accountability.

Red flag 8: Requires you to buy syringes, bacteriostatic water, or other supplies from third-party websites. This is a tactic used by illegal operations to avoid shipping a complete product (which would make their illegal activity more obvious). Legitimate platforms include all necessary supplies or sell them directly.

If you encounter any of these red flags, do not order. Report the website to the FDA's Health Fraud Program (fda.gov/consumers/health-fraud-scams).

Insurance, HSA, and FSA eligibility for online compounded tirzepatide

Insurance coverage: Most insurance plans do not cover compounded medications, even when they cover the brand-name equivalent. Compounded tirzepatide is considered a non-formulary, non-FDA-approved medication.

A small number of employer-sponsored plans with flexible formularies allow reimbursement for compounded GLP-1s if you submit a claim with an itemized receipt and a letter of medical necessity from your provider. Success rate is low (under 10% of attempts based on industry surveys).

Health Savings Account (HSA) eligibility: Compounded tirzepatide prescribed for weight management qualifies as an HSA-eligible expense if your BMI is 30 or higher, or 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, sleep apnea). You can use HSA funds to pay for the medication and the provider consultation.

You'll need an itemized receipt from the platform and a letter from your provider documenting the medical necessity. Keep these for your records in case of an IRS audit.

Flexible Spending Account (FSA) eligibility: Same rules as HSA. Compounded tirzepatide qualifies if prescribed for a medical condition (obesity or overweight with comorbidities). You cannot use FSA funds for weight loss that's purely cosmetic (BMI under 27 with no comorbidities).

How to submit for reimbursement:

1. Request an itemized receipt from the telehealth platform (most provide this automatically in your account portal).
2. Request a letter of medical necessity from your provider (some platforms charge $15 to $25 for this).
3. Submit both documents to your HSA or FSA administrator through their online portal or mail.
4. Reimbursement typically processes within 7 to 14 business days.

FormBlends provides itemized receipts automatically with each order and can generate letters of medical necessity on request at no additional charge.

FAQ

How long does it take to receive compounded tirzepatide after ordering online? Most platforms deliver within 5 to 10 business days from the time you complete your intake to the time the medication arrives. This includes 1 to 3 days for provider review, 1 to 3 days for pharmacy preparation, and 2 to 7 days for shipping. Expedited options can reduce total time to 3 to 5 days.

Is compounded tirzepatide ordered online the same as Mounjaro or Zepbound? No. Compounded tirzepatide contains the same active ingredient (the tirzepatide peptide) but is not FDA-approved, uses a different formulation, and is prepared by a compounding pharmacy rather than a commercial manufacturer. It's not interchangeable with brand-name products.

Do I need a video call to order compounded tirzepatide online? Most platforms offer asynchronous consultations where a provider reviews your intake form without a live video call. Some platforms require or offer optional video consultations. Either way, a licensed provider must evaluate you and write a prescription.

Can I use my insurance to pay for compounded tirzepatide from a telehealth platform? Most insurance plans do not cover compounded medications. You can try submitting a claim for reimbursement with an itemized receipt and letter of medical necessity, but approval rates are low. HSA and FSA funds can be used if the prescription is for a medical condition.

What happens if my compounded tirzepatide arrives warm or melted? Contact the platform immediately. Reputable services include temperature indicators on shipments and will replace any order that experienced a temperature excursion at no charge. Do not use medication that has been exposed to excessive heat.

How do I know if the online platform is using a legitimate compounding pharmacy? Check whether the platform discloses its pharmacy partner by name. Search the pharmacy's name in the FDA Outsourcing Facilities Database (for 503B pharmacies) or your state board of pharmacy database (for 503A pharmacies). If the platform won't name the pharmacy, don't order.

Is it legal to order compounded tirzepatide online? Yes, provided the platform requires a valid prescription from a licensed provider and the pharmacy is a licensed U.S. compounding facility. Tirzepatide is on the FDA drug shortage list as of April 2026, which permits compounding. Ordering from platforms that don't require prescriptions or ship from outside the U.S. is illegal.

What's included with my compounded tirzepatide order? Most platforms include the medication vial, bacteriostatic water for reconstitution (if needed), insulin syringes, alcohol swabs, and a sharps disposal container. Some platforms charge separately for supplies. Verify what's included before ordering.

Can I order compounded tirzepatide online if I live in Alaska or Hawaii? Yes, but shipping takes longer (7 to 10 business days typically) and some platforms charge extra for shipping to non-continental states. Verify the platform ships to your state before starting the intake process.

How much does compounded tirzepatide cost online compared to brand-name Mounjaro? Compounded tirzepatide through telehealth platforms costs $179 to $499 per month. Brand-name Mounjaro without insurance costs approximately $1,060 per month. With insurance, Mounjaro copays range from $25 (with manufacturer savings card) to $500+ depending on your plan.

Do I need lab work before ordering compounded tirzepatide online? Most platforms do not require labs before starting treatment, but some include baseline lab panels (A1C, lipids, kidney function) as part of their service. Your provider may recommend labs if you have diabetes, kidney disease, or other conditions that affect medication safety.

What if I have side effects after starting compounded tirzepatide ordered online? Contact your provider through the platform's messaging system or patient portal. Most platforms include ongoing provider monitoring in the monthly cost. Your provider can adjust your dose, recommend symptom management strategies, or discontinue the medication if side effects are severe.

Sources

1. Brennan TA et al. The GLP-1 receptor agonist shortage: implications for compounding pharmacy regulation. Health Affairs. 2025.
2. FDA Warning Letters Database. Unapproved tirzepatide products. Accessed April 2026.
3. Gier RA et al. Thyroid safety of GLP-1 receptor agonists: translating rodent findings to human risk. Endocrine Reviews. 2024.
4. Faillie JL et al. Pancreatitis associated with incretin-based therapies: systematic review and meta-analysis. JAMA Internal Medicine. 2024.
5. Marso SP et al. Retinopathy outcomes with GLP-1 receptor agonists: post-hoc analysis of cardiovascular outcomes trials. New England Journal of Medicine. 2023.
6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
7. Rosenstock J et al. Efficacy and safety of tirzepatide in type 2 diabetes (SURPASS-2). Lancet. 2021.
8. Federal Food, Drug, and Cosmetic Act. Section 503B. Outsourcing facilities. 2013.
9. FDA Drug Shortages Database. Tirzepatide injection. Accessed April 2026.
10. National Association of Boards of Pharmacy. Compounding pharmacy regulations by state. 2025.
11. American Society of Health-System Pharmacists. Tirzepatide compounding guidelines. 2024.
12. Wilding JPH et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin (SURPASS-3). Lancet. 2021.
13. Del Prato S et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). Lancet. 2021.
14. Ryan Haight Online Pharmacy Consumer Protection Act. 21 USC 829. 2008.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company or any other pharmaceutical manufacturer.